Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Accenture
Cantor Fitzgerald
Farmers Insurance
Medtronic

Generated: March 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Asimadoline

« Back to Dashboard

US Patents for Asimadoline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Asimadoline ➤ Sign Up Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof ➤ Sign Up
Asimadoline ➤ Sign Up Acrylacetamides Merck Patent Gesellschaft mit beschrankter Haftung (Darmstadt, DE) ➤ Sign Up
Asimadoline ➤ Sign Up Kappa-opiate agonists for inflammatory bowel disorders Merck Patent Gesellschaft mit Beschrankter Haftung (DE) ➤ Sign Up
Asimadoline ➤ Sign Up DHA-pharmaceutical agent conjugates of taxanes Neuromedica, Inc. (Conshohocken, PA) ➤ Sign Up
Asimadoline ➤ Sign Up Kappa-opiate agonists effective in the treatment of postoperative ileus Merck Patent Gesellschaft mit Beschrankter Haftung (DE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Asimadoline

Drugname Country Document Number Estimated Expiration Related US Patent
Asimadoline European Patent Office 3324975 2035-07-22 ➤ Sign Up
Asimadoline World Intellectual Property Organization (WIPO) 2017015309 2035-07-22 ➤ Sign Up
Asimadoline Austria 168368 2012-05-09 ➤ Sign Up
Asimadoline Australia 3834193 2012-05-09 ➤ Sign Up
Asimadoline Australia 662051 2012-05-09 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Mallinckrodt
McKinsey
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.